Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
The American Journal of Managed Care
|
August 31, 2018
Economic implications with newer agents to reduce cardiovascular risk in diabetes
Carrie McAdam-Marx
The American Journal of Managed Care
|
August 25, 2022
Addressing healthcare disparities and managed care considerations with continuous glucose monitoring
Carrie McAdam-Marx
The American Journal of Managed Care
|
July 13, 2013
Economic implications of type 2 diabetes management
Carrie McAdam Marx
Journal of Managed Care & Specialty Pharmacy
|
February 25, 2023
Short-term cost-effectiveness analysis of tirzepatide for the treatment of type 2 diabetes in the United States
Xiaotong Zhang, Carrie McAdam Marx
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 9, 2012
Implementation of a pharmacist-managed diabetes program
Brandon T Jennings, Carrie McAdam Marx
Clinical Medicine Insights. Endocrinology and Diabetes
|
August 11, 2012
Treatment of type 1 and type 2 diabetes mellitus with insulin detemir, a long-acting insulin analog
Jason R Young, Carrie McAdam-Marx
The American Journal of Managed Care
|
November 13, 2008
Cost-effectiveness of insulin analogs
Diana I Brixner, Carrie McAdam-Marx
Diabetes, Obesity & Metabolism
|
March 21, 2025
Real-world effectiveness of tirzepatide versus semaglutide for weight loss in overweight or obese patients in an ambulatory care setting
Huong Trinh, Anthony Donovan, Carrie McAdam-Marx
Expert Review of Cardiovascular Therapy
|
May 23, 2015
Once-weekly exenatide as a treatment for Type 2 diabetes
Marisa B Schauerhamer, Holly Gurgle, Carrie McAdam-Marx
Journal of Managed Care & Specialty Pharmacy
|
June 29, 2021
Short-term cost-effectiveness of oral semaglutide for the treatment of type 2 diabetes mellitus in the United States
Jiayu Cui, Donald G Klepser, Carrie McAdam-Marx
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
The American Journal of Managed Care
|
August 31, 2018
Economic implications with newer agents to reduce cardiovascular risk in diabetes
Carrie McAdam-Marx
The American Journal of Managed Care
|
August 25, 2022
Addressing healthcare disparities and managed care considerations with continuous glucose monitoring
Carrie McAdam-Marx
The American Journal of Managed Care
|
July 13, 2013
Economic implications of type 2 diabetes management
Carrie McAdam Marx
Journal of Managed Care & Specialty Pharmacy
|
February 25, 2023
Short-term cost-effectiveness analysis of tirzepatide for the treatment of type 2 diabetes in the United States
Xiaotong Zhang, Carrie McAdam Marx
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 9, 2012
Implementation of a pharmacist-managed diabetes program
Brandon T Jennings, Carrie McAdam Marx
Clinical Medicine Insights. Endocrinology and Diabetes
|
August 11, 2012
Treatment of type 1 and type 2 diabetes mellitus with insulin detemir, a long-acting insulin analog
Jason R Young, Carrie McAdam-Marx
The American Journal of Managed Care
|
November 13, 2008
Cost-effectiveness of insulin analogs
Diana I Brixner, Carrie McAdam-Marx
Diabetes, Obesity & Metabolism
|
March 21, 2025
Real-world effectiveness of tirzepatide versus semaglutide for weight loss in overweight or obese patients in an ambulatory care setting
Huong Trinh, Anthony Donovan, Carrie McAdam-Marx
Expert Review of Cardiovascular Therapy
|
May 23, 2015
Once-weekly exenatide as a treatment for Type 2 diabetes
Marisa B Schauerhamer, Holly Gurgle, Carrie McAdam-Marx
Journal of Managed Care & Specialty Pharmacy
|
June 29, 2021
Short-term cost-effectiveness of oral semaglutide for the treatment of type 2 diabetes mellitus in the United States
Jiayu Cui, Donald G Klepser, Carrie McAdam-Marx
Page
of 8